FROM CHEMISTRY TO CURES

Creating Small Molecule Drugs for Viral Infections and Liver Diseases

Learn More

Enanta’s diversified portfolio is focused primarily on unmet medical needs such as non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), respiratory syncytial virus (RSV) and hepatitis B virus (HBV)